Creativity Group for Borderline Personality Disorder

The investigators hypothesize that a creativity skills group for Borderline Personality Disorder can reduce symptoms of BPD, depression, and anxiety.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Borderline Personality Disorder Mental Disorders Personality Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

SUNY Upstate Medical University

Syracuse, New York, 13210, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older
participant self-reports clinical diagnosis of Borderline Personality Disorder
currently seeing an individual therapist on a regular basis

Treatment and study plan

creativity group

Other

This is a creativity group intervention. There will be 4 groups. Each group has one session per week. Each session is a duration of two hours.

Primary outcomes

Borderline Evaluation of Severity Over Time (BEST)

Time frame: baseline, 5th week, post-intervention (week 8)

Secondary outcomes

Beck Depression Inventory (BDI)

Time frame: baseline, week 5, week 8

Sponsors and collaborators

Lead sponsor

State University of New York - Upstate Medical University

Other

Registry information

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2011
First posted: Apr 28, 2011
Registry last updated: Oct 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed